Migraine is not simply a bad headache — it is a complex neurological disorder that affects an estimated one billion people worldwide and ranks among the leading causes of disability globally, according to research published in peer-reviewed literature. For roughly one-third of people with chronic migraine, standard treatments including triptans, preventive medications, and nerve blocks do not provide adequate relief. At Awakenings by Northwest Ohio Ketamine in Toledo, we offer IV ketamine for migraines as an option for patients with chronic migraines who have not found sufficient relief through conventional care.
Understanding Migraine as a Neurological Condition
A migraine is a neurological event driven by abnormal brain activity, not simply a vascular problem or tension in the head. Research has established that migraine involves a process called cortical spreading depression — a wave of electrical activity followed by suppression that moves across the brain’s cortex — as well as activation of the trigeminal nerve system, which is the primary pain pathway in the head and face. The result is not just severe head pain, but a constellation of symptoms that can include nausea, extreme sensitivity to light and sound, visual disturbances, and in some cases neurological symptoms such as temporary weakness or speech changes.
Chronic migraine is defined as 15 or more headache days per month, with at least 8 of those meeting migraine criteria. Reaching that threshold places enormous limits on daily functioning — work, relationships, and basic activities become difficult to maintain. For patients in this category whose condition has not responded to multiple treatment approaches, the medical designation shifts to treatment-resistant chronic migraine, and that is the population we are most positioned to help at Awakenings.
Why Standard Migraine Treatments Fall Short for Some Patients
First-line migraine treatments work by targeting serotonin receptors, constricting blood vessels, or reducing inflammation in the trigeminal pathway. Triptans, for example, are effective for many patients during an acute migraine but do nothing to prevent future episodes. Preventive medications — including beta-blockers, anticonvulsants, and certain antidepressants — reduce migraine frequency for some patients but carry significant side effect profiles and lose effectiveness over time for others.
CGRP (calcitonin gene-related peptide) inhibitors represent a newer class of preventive medications with strong clinical evidence, but they are not universally covered by insurance and are not effective for every patient. Nerve blocks, including occipital nerve blocks and trigger point injections, offer temporary relief for some but require repeated procedures and produce inconsistent results. When a patient has worked through this cascade of options without achieving adequate control, the question becomes: what else is available?
How IV Ketamine Works for Migraine Relief
Ketamine is an anesthetic medication that has been used safely in medical settings for more than five decades. Its application for chronic pain — including migraine — stems from its action on NMDA receptors (N-methyl-D-aspartate receptors), which are a critical component of the glutamate system. Glutamate is the brain’s primary excitatory neurotransmitter, and research supports the role of glutamate and NMDA receptor activity in the central sensitization that underlies chronic pain conditions, including refractory migraine.
Central sensitization refers to a state in which the nervous system becomes persistently activated and amplified, essentially stuck in a pain-processing mode even in the absence of an ongoing injury. When the NMDA receptor is overactivated, pain signals are amplified and the threshold for triggering a migraine lowers over time. By blocking NMDA receptors, IV ketamine interrupts this cycle — reducing the central sensitization that makes chronic migraines so difficult to control with peripheral treatments alone. To learn more about how stress and neurological triggers intersect with migraine, see our blog post on whether stress can cause migraines.
At Awakenings, we administer ketamine by intravenous infusion, which we consider the preferred delivery method because it allows our providers to control the dose in real time, adjust as needed, and ensure the fastest possible therapeutic effect. Each patient is monitored throughout the infusion — pulse, oxygen levels, and blood pressure are tracked continuously, and our team is present to provide support. You will not be sedated; most patients remain awake and aware, though many describe a deeply relaxed or altered perceptual state during the session.
What the Research Says
Clinical evidence supporting ketamine for chronic pain conditions, including refractory migraine, has grown substantially. Research published in peer-reviewed literature demonstrates ketamine’s effectiveness in treating chronic pain through its action on NMDA receptors involved in central pain sensitization. Separately, research on migraine pathophysiology identifies the glutamate system and trigeminal activation as central mechanisms — the same pathways that IV ketamine targets.
For patients with migraine who have also developed depression or anxiety — which frequently co-occur with chronic pain conditions — IV ketamine may address both dimensions simultaneously. Research confirms a strong bidirectional relationship between chronic pain and mental health conditions including depression, with each worsening the other over time. Our blog on the connection between chronic pain and depression explores this relationship in detail. Treating the pain without addressing the mental health component, and vice versa, often produces incomplete results. At Awakenings, our team includes both Dr. William James, our founder and director with a background in anesthesiology and pain management, and Ben Wagner, PMHNP-BC, our board-certified Psychiatric Mental Health Nurse Practitioner — a combination that allows us to hold both dimensions of a patient’s presentation in view.
Results vary by individual, and IV ketamine is not appropriate for every patient with chronic migraine. A thorough evaluation of your medical history, prior treatments, and current medications is required before any treatment plan is developed.
What to Expect at Awakenings
Your experience at Awakenings begins with a free initial consultation — no referral required, though we welcome documentation from your neurologist or primary care provider if you have it. During that consultation, we review your migraine history, prior treatments and responses, and any relevant medical conditions to determine whether therapeutic ketamine infusions are appropriate for your situation.
If you move forward, your infusion sessions take place in a private, comfortable room at our clinic at 7053 Central Ave in Toledo, Ohio. Our clinic serves the broader Ohio and Michigan area. Each session involves continuous monitoring by our medical team, and you will have a call button available throughout. Because ketamine may temporarily affect your coordination and perception, you will need a driver to take you home — you should not drive or operate machinery for 24 hours following an infusion.
Addressing the Cost Question
We do not accept insurance as a primary payer for IV ketamine infusions. However, some insurance plans will reimburse all or a portion of treatment as an out-of-network service, and we will provide the documentation needed to support your claim if that is the case with your plan. For patients who need financing, we offer CareCredit, a medical funding company that allows you to spread the cost of treatment. Active and former military with a valid ID or DD-214, and first responders with a badge, receive a 25 percent discount on treatment. We discuss the full financial picture with every patient before any commitment is made — cost should never be a barrier to at least having a conversation about your options.
We understand that the prospect of trying yet another treatment after a long history of unsuccessful ones can be discouraging. If you have reached that point, we want to be direct with you: we cannot guarantee outcomes, and no ethical provider can. What we can offer is a thorough evaluation, a clinically grounded treatment approach, and a team that takes treatment-resistant chronic pain seriously. You can also review answers to common questions on our Ketamine FAQs page.
Frequently Asked Questions
Is IV ketamine approved by the FDA for migraine treatment? IV ketamine is not FDA-approved specifically for migraine. It is used off-label for chronic pain conditions including refractory migraine, based on clinical evidence and physician judgment. Off-label use by qualified medical providers is a standard and legal practice in medicine. We discuss what this means for your situation during your free consultation.
How many infusions will I need for migraine relief? For chronic pain conditions, our standard initial course involves a series of infusions — the specific number and frequency are determined based on your individual presentation and response. Some patients experience meaningful relief during the initial course; others may need maintenance infusions over time. Results vary by individual, and we discuss realistic expectations with every patient before treatment begins.
Can I continue my current migraine medications during ketamine treatment? In most cases, yes — IV ketamine does not interact with the majority of migraine medications. MAO inhibitors may require tapering before treatment, and we review your full medication list during your consultation. We encourage you to discuss any medication changes with all of your providers.
What does the infusion feel like? Most patients describe a state of deep relaxation during the infusion, sometimes accompanied by altered perceptions of time, space, or the body. Some patients find the experience significant enough that they record their session to review afterward. Our team is present throughout and you have a call button if you need support at any point.
Will one infusion be enough? A single infusion may provide temporary relief for some patients, but the research on sustained results for chronic pain conditions generally supports a series of infusions rather than a single treatment. We set clear expectations with every patient at the outset.
Key Takeaways
- Migraine is a complex neurological disorder driven by cortical spreading depression and trigeminal activation — not simply tension or vascular changes.
- Central sensitization — the nervous system becoming persistently amplified in pain-processing — is a key mechanism in chronic migraine that peripheral treatments often cannot fully address.
- IV ketamine blocks NMDA receptors in the glutamate system, which may interrupt the central sensitization cycle underlying treatment-resistant chronic migraine.
- At Awakenings in Toledo, IV ketamine is administered by a team with backgrounds in anesthesiology, pain management, and behavioral health — addressing both the pain and mental health dimensions that frequently co-occur in chronic migraine patients.
- Results vary by individual; IV ketamine is not appropriate for every patient, and candidacy requires a thorough evaluation. We offer a free initial consultation with no referral required.
Chronic migraine that has not responded to standard treatments deserves more than another prescription adjustment. At Awakenings by Northwest Ohio Ketamine in Toledo, our team will evaluate your full history and give you an honest assessment of whether IV ketamine infusion therapy may offer a meaningful path forward. Call us at 419-406-4263 or schedule a free consultation with our team today.
References
Research on migraine pathophysiology and treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC9506374/
Research on ketamine for chronic pain via NMDA receptor action. https://www.ncbi.nlm.nih.gov/books/NBK539824/
Research on NMDA receptor and glutamate system mechanisms. https://pmc.ncbi.nlm.nih.gov/articles/PMC5148235/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. IV ketamine infusion therapy for migraine should only be considered under the supervision of a qualified medical provider familiar with your full medical history and prior treatment responses. Individual results vary. If you are experiencing a medical emergency, please call 911 or go to your nearest emergency room.